ArticleOncotarget2015

Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.

Sheng-Huei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.